Larimar Therapeutics, Inc. · NASDAQ:LRMR
Goldman Sachs Group Inc's stake in Larimar Therapeutics, Inc. fell to 4.10% (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 13, 2025
Goldman Sachs Group Inc's stake in Larimar Therapeutics, Inc. fell to 4.10%, 2,600,211 shares, as a passive investor on Mar 31, 2025. Filed May 13, 2025 (Schedule 13G/A).
- Stake
- 4.10%
- Shares
- 2,600,211
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| THE GOLDMAN SACHS GROUP, INC. | 4.10% | 2,600,211 |
| GOLDMAN SACHS & CO. LLC | 4.10% | 2,600,211 |
Source
Related
- Larimar Therapeutics, Inc.
- Goldman Sachs Group Inc
- Larimar Therapeutics, Inc. shareholders
- Form 4 · Harlow John B. Jr. · Oct 1, 2026
- Form 4 · Hamilton Thomas Edward · Jul 8, 2026
- Schedule 13G/A · Blue Owl Capital Holdings LP · May 14, 2026
- Schedule 13G/A · Millennium Management LLC · Apr 30, 2026
- Schedule 13D/A · Deerfield Management Company, L.P. · Mar 2, 2026